Apr 2021 $54 M No. 5 $50 to $250 million 22
ViaCyte Inc.: Raise no. 5, Apr 2021 × Investors in this round 22 investors had bought by the notice of Apr 22, 2021: 22 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $54 M of $59 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Anne G. Sandan · Executive Officer Brittany G. Bradrick · Executive Officer Elizabeth G. Bui · Executive Officer Howard G. Foyt · Executive Officer Kevin G. D'Amour · Executive Officer Michael Yang · Executive Officer, Director Steve G. White · Executive Officer Amir R. Zamani · Director Asish R. Xavier · Director Fred A. Middleton · Director Ian G. Smith · Director Lucian A. Iancovici · Director Mark G. Foletta · Director Paul G. Hastings · Director Sandra G. Poole · Director Steven R. Altman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Includes amounts paid both in cash and pursuant to automatic conversion of indebtedness.”Signed by Anne Sandan, Vice President, Finance, Corporate Controller & Secretary. Source: SEC Form D, newest notice filed Apr 22, 2021. Read the notice at the SEC .
equity SEC Mar 2020 $33 M No. 4 $10 to $50 million 17
ViaCyte Inc.: Raise no. 4, Mar 2020 × Investors in this round 17 investors had bought by the notice of Apr 2, 2020: 17 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $33 M of $36 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Anne G. Sandan · Executive Officer Howard G. Foyt · Executive Officer Kevin G. D'Amour · Executive Officer Liz G. Bui · Executive Officer Mark G. Zimmerman · Executive Officer Paul Laikind · Executive Officer, Director Steve G. Kradjian · Executive Officer Adam R. Koppel · Director Asish R. Xavier · Director Fred A. Middleton · Director Heath A. Lukatch · Director Ian G. Smith · Director Mark G. Foletta · Director Paul G. Hastings · Director Sandra G. Poole · Director Steven R. Altman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Includes amounts paid both in cash and pursuant to automatic conversion of indebtedness.”Signed by Anne Sandan, Vice President, Finance, Corporate Controller & Secretary. Source: SEC Form D, newest notice filed Apr 2, 2020. Read the notice at the SEC .
equity SEC Nov 2018 $36 M No. 3 $10 to $50 million 9
ViaCyte Inc.: Raise no. 3, Nov 2018 × Investors in this round 9 investors had bought by the notice of Dec 3, 2018: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $36 M of $90 M offered; $54 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions $2,743,800
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Anne G. Sandan · Executive Officer Elizabeth G. Bui · Executive Officer Howard G. Foyt · Executive Officer Kevin G. D'Amour · Executive Officer Paul Laikind · Executive Officer, Director Adam R. Koppel · Director Asish R. Xavier · Director Fred A. Middleton · Director Heath A. Lukatch · Director Mark G. Foletta · Director Steven R. Altman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Raymond James & Associates, Inc. (CRD 705) · St. Petersburg, Florida Sold in all US states Remarks in the notice On fees: “Represents an estimate of fees that may be paid by the Company to a placement agent upon receipt of the total offering amount listed in Section 13 herein.”On the amounts: “Includes amounts paid both in cash and pursuant to automatic conversion of indebtedness.”Signed by Anne Sandan, Vice President, Finance, Corporate Controller & Secretary. Source: SEC Form D, newest notice filed Dec 3, 2018. Read the notice at the SEC .
equity SEC Aug 2014 $15 M No. 2 $10 to $50 million 1
ViaCyte Inc.: Raise no. 2, Aug 2014 × Investors in this round 1 investor had bought by the notice of Aug 21, 2014: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $15 M of $15 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Securities offered consist of a convertible promissory note and the shares of preferred or common stock issuable upon the conversion thereof. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Allan G. Robins · Executive Officer Anne G. Sandan · Executive Officer Elizabeth G. Bui · Executive Officer Howard G. Foyt · Executive Officer Kevin G. D'Amour · Executive Officer Michael G. Scott · Executive Officer Paul Laikind · Executive Officer, Director Donald J. Elmer · Director Franklin P. Johnson · Director Fred A. Middleton · Director Mark G. Foletta · Director Orville G. Kolterman · Director Steven R. Altman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Anne Sandan, Sr. Director, Finance, Controller & Secretary. Source: SEC Form D, newest notice filed Aug 21, 2014. Read the notice at the SEC .
debt, options SEC Jul 2013 $12 M No. 1 $10 to $50 million 55
ViaCyte Inc.: Raise no. 1, Jul 2013 × Investors in this round 55 investors had bought by the notice of Jul 19, 2013: 55 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $12 M of $27 M offered; $15 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Securities offered consist of convertible preferred stock, warrants exercisable for shares of convertible preferred stock and common stock and the underlying preferred and common stock issuable upon t
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Allan K. Robin · Executive Officer Anne K. Sandan · Executive Officer Howard K. Foyt · Executive Officer Kevin K. D'Amour · Executive Officer Liz K. Bui · Executive Officer Michael K. Scott · Executive Officer Paul Laikind · Executive Officer, Director Asish K. Xavier · Director Donald J. Elmer · Director Franklin P. Johnson · Director Fred A. Middleton · Director Orville G. Kolterman · Director Steven R. Altman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Amounts listed include the following amounts receivable by the Issuer upon exercise of common stock warrants and preferred stock warrants: subsection (a) - $2,175,642; subsection (b) - $1,528,637. Such warrants have not been exercised.”Signed by Anne Sandan, Sr. Director, Finance, Controller & Secretary. Source: SEC Form D, newest notice filed Jul 19, 2013. Read the notice at the SEC .
equity, options SEC